Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$203.5M
+2.3% from 2023
Prescriptions
215K
$946.50 per claim
Patients
47K
24,897 prescribers
Total spending, 2024
$203.5M
$4,366.06 per patient
Medicare prescription drug plans paid $203.5M for Xigduo Xr in 2024, for 214,951 prescriptions and refills to 46,597 patients (up 2.3% from 2023). The average cost per claim was $946.50.
Texas had the highest Medicare cost for Xigduo Xr in 2024: $33.3M for 32,305 claims, followed by Puerto Rico ($23.3M).
Eliscer Guzman, internal medicine in New York, NY, had the highest Medicare cost for Xigduo Xr in 2024: 730 claims costing $664K.
Xigduo Xr is made by AstraZeneca PLC (AZN), listed in the Medicare spending data as Astrazeneca.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Eliscer Guzman New York, NY | Internal Medicine | 730 | 226 | $664K |
| Alex N Gonzalez Bossolo San Juan, PR | Endocrinology | 531 | 130 | $491K |
| Edwin A Torres |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2023 | 22,967 | 196,384 | 43,033 | $198.8M |
| 2024 | 24,897 | 214,951 | 46,597 | $203.5M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims |
|---|
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Nurse Practitioner |
| 538 |
| 113 |
| $458K |
| Anardi A Agosto Mujica Cayey, PR | Endocrinology | 322 | 85 | $427K |
| Zhu-Ping Zhou Flushing, NY | Internal Medicine | 436 | 74 | $410K |
| Hernan R Baquerizo Miami, FL | Endocrinology | 447 | 85 | $406K |
| Kandaswamy Jayaraj Beaumont, TX | Endocrinology | 371 | 94 | $401K |
| Winston C Wong La Palma, CA | Internal Medicine | 395 | 76 | $395K |
| Vinay Kapoor Bayside, NY | Endocrinology | 324 | 79 | $384K |
| Daniel S Tung Houston, TX | Endocrinology | 300 | 78 | $362K |
| Jack Azad Los Angeles, CA | General Practice | 234 | 72 | $328K |
| Sheila Mercado Manati, PR | Endocrinology | 458 | 82 | $307K |
| Sergio F Rovner El Paso, TX | Endocrinology | 312 | 92 | $307K |
| Nixzaliz Rodriguez Rivera Ponce, PR | Endocrinology | 441 | 73 | $303K |
| Luis J Rodriguez-Saenz Cayey, PR | Family Practice | 435 | 55 | $277K |
| Jerry L Jurado Union City, NJ | Family Practice | 216 | 72 | $274K |
| Carlos N Casas Laredo, TX | Internal Medicine | 253 | 58 | $273K |
| Michael K Lai Santa Maria, CA | Endocrinology | 216 | 53 | $258K |
| Enrique J Griego McAllen, TX | Family Practice | 243 | 73 | $256K |
| Carlos M Martinez Rivera Mayaguez, PR | Endocrinology | 345 | 80 | $245K |
| Himani Chandra Cortlandt Manor, NY | Endocrinology | 221 | 45 | $233K |
| Virmarie Caban Soto Anasco, PR | General Practice | 321 | 43 | $229K |
| Sanjay N Lakhani Highland Park, MI | General Practice | 378 | 59 | $226K |
| Stanley Mathew Saint Peters, MO | Endocrinology | 196 | 43 | $225K |
| Rose M Roman Torres Mayaguez, PR | Endocrinology | 317 | 52 | $220K |
| Spending |
|---|
| Astrazeneca AZN | 215,012 | $203.5M |